Urine Biomarker Test Improves Prediction of Donor Kidney Outcomes
A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.
A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.
The card pairs with the Ortho Vision Platform to provide a complete gel-based DAT solution for transfusion medicine laboratories.
Verici Dx signed a licensing agreement with Thermo Fisher on an assay for pre-transplant prognostic testing of early kidney rejection risks.
The transaction includes proprietary IP and technology for blood-based immune therapy monitoring and for transplant rejection testing.
Read MoreThe Ortho Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention.
Read MoreThe test provides standardized, high-quality results to help better assess the risk of complications caused by the BK virus in transplant patients.
Read MoreWith the test, the team demonstrated organ transplant patients are very capable of achieving a good immune response to covid-19 despite immunosuppression.
Read MoreBy integrating von Willebrand factor antigen into their planning model, researchers significantly increased the accuracy of predicting the probability of dying while on the waiting list for a liver transplant.
Read MoreThe Cobas Zika test detects Zika virus RNA in samples of human plasma and is intended for use in screening blood donations.
Read MoreDisqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read MoreDiscovery by Medical University of Vienna research team may lead to early identification of dangerous complications among transplant patients.
Read MoreAdoption of the technology is based on the premise that healthcare providers need to get the right bag of blood products to the right patient at the right time.
Read MoreWith an increasing US prevalence of vector-borne illnesses such as Lyme disease, there is a pressing need to improve clinical diagnostics.
Read MoreBD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read MoreAt FDA urging, Beckman Coulter has repeated its Class I recall letters for three hematology analyzers.
Read MoreRack Reader Traces 2D-Coded Tubes Synchronized reader and software Optimized for rapid and...
Read MoreThe system leverages innovative ultrasound technology to provide rapid viscoelastic results in 15 minutes or less.
Read MoreAssay enables screening for the presence of four clinically relevant species of the Babesia parasite in donated blood.
Read More